论文部分内容阅读
目的:探讨超早期静脉溶栓治疗急性心肌梗死的临床疗效。方法:将我院2000年以来收治的急性心肌梗死病人48例,随机分为两组各24例,对照组采用硝酸甘油,低分子肝素,中医活血化瘀等治疗,治疗组在对照组的基础上加用尿激酶静脉溶栓。结果:治疗组在溶栓后24h显著进步和进步20例,有效率83.3%,对照组用药后24h内显著进步和进步共6例,有效率25%,两组比较差异有显著性(P<0.01)。结论:尿激酶超早期静脉溶栓治疗急性心肌梗死安全有效。
Objective: To investigate the clinical effect of ultra-early intravenous thrombolysis in the treatment of acute myocardial infarction. Methods: Forty-eight patients with acute myocardial infarction admitted to our hospital from 2000 were randomly divided into two groups of 24 cases. The control group was treated with nitroglycerin, low molecular weight heparin and traditional Chinese medicine. Urokinase plus intravenous thrombolysis. Results: In the treatment group, significant improvement and progress were made in 20 cases at 24 hours after thrombolysis, with an effective rate of 83.3%. In the control group, significant improvement and progress were made in 6 cases after 6 hours of treatment, with an effective rate of 25%. There was significant difference between the two groups (P < 0.01). Conclusion: Ultra-early intravenous thrombolytic therapy of Urokinase in acute myocardial infarction is safe and effective.